Back

Insufficient long-term LDL-cholesterol management in patients with familial hypercholesterolemia 5 years after an acute coronary syndrome

28 August 2023 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention Secondary Prevention ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Kristina Krasieva

Centre for Primary Care and Public Health (Unisante), Lausanne (Switzerland)

8 More presentations in this session

Presentation thumbnail
Real world prognostic impact and predictors of adherence to statin therapy after STEMI on first year follow up: results from the FAST STEMI registry
Doctor L. Carmagnola (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Long-term aspirin adherence and risk of cardiovascular events and death after myocardial infarction: A nationwide cohort study
Doctor A. Kristensen (Frederiksberg, DK)
Abstract Slides Video
Presentation thumbnail
A global perspective on cardiovascular risk factor management in patients with CHD and different educational level: SURF CHD II
Ms A. Marza Florensa (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Lower income is associated with non-persistence to statin treatment after a first myocardial infarction
Mr K. Ma (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Lipid assessment and achievement of secondary prevention european society of cardiology guideline targets in patients with atherosclerotic cardiovascular disease with and without depression
Doctor R. Summers (Swansea, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary prevention

The Event

Event poster

ESC Congress 2023

28 August 2023 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparing achieved treatment targets of genetically confirmed familial hypercholesterolaemia patients followed by primary versus secondary care. a real-world experience from a tertiary welsh centre.
thumbnail
Congress Presentation
Therapeutic gaps in low-density lipoprotein cholesterol management have narrowed over time but remain wide: a wide study of 40,141 acute coronary syndrome patients from 2016 to 2021
thumbnail
Congress Presentation
Successful ESC recommended LDL-C reduction after percutaneous coronary intervention: real-world data from the contemporary ZON-HR registry.

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources